How much does G802 pay?

The current OHIP fee for G802 is $83.80, effective 2025-04-01, per the Ontario Schedule of Benefits.

How do I bill G802 to OHIP?

G802 is submitted through OHIP's MCEDT claims system, either directly or via billing software. SnapBill validates G802 claims against the Schedule of Benefits rules before submission.

What codes are related to G802?

Codes related to G802 in the Schedule of Benefits include G800, G801, G804, G805.

All codes

G802

G802 – Hyperbaric Oxygen Therapy - after 2 hours in chamber

OHIP Diagnostic and Therapeutic Procedures Code — DIAGNOSTIC AND THERAPEUTIC PROCEDURES · Schedule of Benefits

Ask a question

Hyperbaric Oxygen Therapy (HBOT) is the service rendered when a physician administers and supervises HBOT. Time is calculated based on the period of physician supervision while each patient receives HBOT inside the chamber. The specific elements of HBOT are those of an assessment, including ongoing monitoring of the patient's condition and intervening as appropriate. This service is for the physician in constant attendance inside the chamber with the patient(s), per session per patient, for each quarter hour or major part thereof after the initial two hours in the chamber. See also G800 and G801 for time preceding this service.

The start and stop times of the service are recorded in each patient's permanent medical record.

G800 G801 G804 G805

HBOT is insured only for the treatment of those internationally recognized indications approved by the ministry.

HBOT is only eligible for payment for idiopathic sudden sensorineural hearing loss (ISSHL) when the following conditions are met: a. The patient is treated concurrently with corticosteroid unless corticosteroids are contraindicated; b. The treatment is initiated within 30 days of a diagnosis of ISSHL; and c. The diagnosis of ISSHL is made or confirmed by an Otolaryngologist prior to the initiation of treatment.

HBOT is only eligible for payment for avascular necrosis (AVN) of bone following diagnostic imaging confirmation of symptomatic early to mid-stage AVN, e.g. Ficat stage I, II, or III or equivalent.

As of April 1, 2026, the following indications were approved by the MOH:

• air or gas embolism

• carbon monoxide poisoning and/or cyanide poisoning

• clostridial myositis and myonecrosis (gas gangrene)

• crush injury, compartment syndrome, and other acute traumatic ischemias

• decompression sickness

• enhancement of healing in selected problem wounds

• exceptional blood loss

• intracranial abscess

• necrotizing soft tissue infections (subcutaneous tissue, muscle, fascia)

• osteomyelitis (refractory)

• delayed radiation injury (soft tissue and bony necrosis)

• skin grafts and flaps (compromised)

• thermal burns

Ready to bill this code?

SnapBill makes OHIP billing simple — auto-filled codes, validation, and batch submission.

Get Started Free Already have an account? Sign in